drugset / Trial / NCT01295099

Keloid Scarring: Treatment and Pathophysiology

NCT01295099

RandomizedSingle-groupOpen-labelTreatment

Summary

To clarify the mechanisms of Keloid scar formation. Elucidate the action and therapeutic value of 5-FU in Keloid scar treatment Identify the genetic link with Keloid scar formation. Quantify the psychological/social impact in keloid scarring patients

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Other / unclassified 10 mg Other
Comparator fluorouracil Small molecule 5 mg Other

Indications